Jonathan Chong practises in intellectual property, with a focus on patent litigation. He has appeared before the Federal Court at the trial of a patent infringement action and for the hearing of an application made pursuant to the Patented Medicines (Notice of Compliance) Regulations (PMNOC Regulations).
Dr. Chong's litigation experience involves medical devices and pharmaceutical products, including small molecule, peptide, monoclonal antibody and vaccine products. These matters pertain to patents covering compounds, salts, crystal forms, formulations and treatment of medical conditions. He has been involved in patent infringement and impeachment actions, and proceedings instituted pursuant to the old and the new PMNOC Regulations.
Dr. Chong's graduate research involved the synthesis and study of porous metal-organic materials. He worked at the National Research Council of Canada and developed green chemical processes and materials derived from renewable resources. His research has been published in leading scientific journals.
Prior to joining our Montréal office, Dr. Chong articled and summered with a leading international law firm specializing in intellectual property.
B.C.L./LL.B., McGill University, 2015
Ph.D., Chemistry, University of British Columbia, 2009
B.Sc.(Hons.), Biochemistry and Chemistry, University of British Columbia, 2002
Memberships and activities
- Canadian Bar Association
- Intellectual Property Institute of Canada
- Young Bar of Montreal
The Federal Court invalidated the claims of a patent asserted in an infringement action, finding the plaintiffs’ choice to advance a broad construction invited the unavoidable validity problems that these claims are obvious and lack novelty..
March 01, 2018
The Federal Court is willing to grant a restrictive protective order to protect commercially sensitive information disclosed during litigation if justified by unusual circumstances..
February 15, 2018